Immunization standards

Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b (fully liquid presentation) (10 dose vial)

Vaccine Trade Name:

Vaccine Type: Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b

Manufacturer: Biological E Limited

Country of Manufacture: India

Date of prequalification: 18 May 2012

NRA of Record: CDSCO

Product Description

Pharmaceutical form: liquid

Presentation: 10 dose vial

Route of administration: intramuscular

Vaccine Vial Monitor: Type 7

Shelf life: 24 months at 2 - 8 °C

Secondary Packaging: box of 24 vials

Cold Chain volume per dose (cm3): 2.9

Preservative: Thiomersal, 0.01% w/v.

Handling of opened multi-dose vials: WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.

Remarks

Share

Last update:

21 March 2014 14:57 CET